L563-0386 Screening compound: N-[(4-chlorophenyl)methyl]-4-[2-(3-methoxyphenoxy)pyrimidin-5-yl]benzamide

L563-0386 Screening compound: N-[(4-chlorophenyl)methyl]-4-[2-(3-methoxyphenoxy)pyrimidin-5-yl]benzamide
L563-0386 Screening compound: N-[(4-chlorophenyl)methyl]-4-[2-(3-methoxyphenoxy)pyrimidin-5-yl]benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L563-0386
N-[(4-chlorophenyl)methyl]-4-[2-(3-methoxyphenoxy)pyrimidin-5-yl]benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L563-0386

Molecular Formula

C25H20ClN3O3 (C25 H20 ClN3 O3)

Compound Name

N-[(4-chlorophenyl)methyl]-4-[2-(3-methoxyphenoxy)pyrimidin-5-yl]benzamide

IUPAC name

N-[(4-chlorophenyl)methyl]-4-[2-(3-methoxyphenoxy)pyrimidin-5-yl]benzamide

SMILES

COc1cccc(Oc(nc2)ncc2-c(cc2)ccc2C(NCc(cc2)ccc2Cl)=O)c1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

445.9

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.108

Distribution Coefficient, logD

5.108

Water Solubility, LogSw

-5.75

Polar Surface Area

58.087

Acid Dissociation Constant (pKa)

11.36

Base Dissociation Constant (pKb)

-0.34

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

8.00

L563-0386 in Drug Discovery

Included in Screening Libraries

Angiogenesis library (14822 compounds)

Autophagy-Targeted Library (4564 compounds)

Akt-Targeted Library (14764 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Infections
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with L563-0386 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L563-0386?
Check Price and Availability of L563-0386, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L563-0386 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L563-0386
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L563-0386
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L563-0386 available by request